当前位置: X-MOL 学术Plant Cell Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Will the EU stay out of step with science and the rest of the world on plant breeding innovation?
Plant Cell Reports ( IF 6.2 ) Pub Date : 2019-11-21 , DOI: 10.1007/s00299-019-02482-2
Petra Jorasch 1
Affiliation  

Innovations in plant breeding like genome editing methods raised questions about the adequacy of established regulatory policies for plant breeding and biotechnology in view of these new breeding methods and the resulting products. Most countries follow the principle approach that only those plants will be regulated under biotech regulations that include a novel combination of genetic material following the Cartagena protocol. In contrast to this, the European Court of Justice interpreted the current EU biotech regulations in a way that these also apply to plants resulting from new mutagenesis breeding, even if these plants are indistinguishable from conventionally bred plants. This ruling created strong reactions and concerns stating that recent technical developments have made the EU GMO Directive no longer fit for purpose. The article describes ongoing policy developments on EU level that might result in an update of current regulations.

中文翻译:

欧盟会在植物育种创新方面与科学及世界其他地区保持步调一致吗?

鉴于基因组编辑方法等植物育种的创新,鉴于这些新的育种方法和所产生的产品,人们对已建立的植物育种和生物技术监管政策的适当性提出了质疑。大多数国家遵循的原则方法是,只有那些植物才能受生物技术法规的管制,其中包括遵循卡塔赫纳协议的新型遗传物质组合。与此相反,欧洲法院以某种方式解释了当前的欧盟生物技术法规,这些法规也适用于新诱变育种产生的植物,即使这些植物与常规育种的植物没有区别。该裁决引起了强烈的反响和担忧,表明最近的技术发展已使欧盟GMO指令不再适合该目的。
更新日期:2019-11-21
down
wechat
bug